Tetraphase Pharmaceuticals, Inc. (TTPH)

4.11
NASDAQ
Prev Close 4.11
Day Low/High 0.00 / 0.00
52 Wk Low/High 3.12 / 46.25
Exchange NASDAQ
Shares Outstanding 36.70B
Market Cap 146.79M
Div & Yield N.A. (N.A)

Latest News

Short Interest In Tetraphase Pharmaceuticals Falls 19.4%

Short Interest In Tetraphase Pharmaceuticals Falls 19.4%

The most recent short interest data has been released for the 06/30/2016 settlement date, which shows a 875,721 share decrease in total short interest for Tetraphase Pharmaceuticals, Inc , to 3,645,836, a decrease of 19.37% since 06/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

First Week of February 2017 Options Trading For Tetraphase Pharmaceuticals (TTPH)

First Week of February 2017 Options Trading For Tetraphase Pharmaceuticals (TTPH)

Investors in Tetraphase Pharmaceuticals, Inc saw new options begin trading this week, for the February 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Tetraphase Pharmaceuticals Presents Antibiotics Pipeline Data At ASM Microbe 2016

Tetraphase Pharmaceuticals Presents Antibiotics Pipeline Data At ASM Microbe 2016

Includes Phase 3 Clinical Trial Data from IGNITE1 and IGNITE2

Monsanto, Amazon and Apple: Doug Kass' Views

Monsanto, Amazon and Apple: Doug Kass' Views

Doug Kass shares his thoughts on shorting financials, and wonders if it will be a Monsanto merger Monday.

Tetraphase Pharmaceuticals (TTPH) Weak On High Volume Today

Tetraphase Pharmaceuticals (TTPH) Weak On High Volume Today

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a weak on high relative volume candidate

Tetraphase Pharmaceuticals (TTPH): Today's Weak On High Volume Stock

Tetraphase Pharmaceuticals (TTPH): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a weak on high relative volume candidate

IMPORTANT DEADLINE REMINDER: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

IMPORTANT DEADLINE REMINDER: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that a class action lawsuit has been filed against Tetraphase Pharmaceuticals, Inc.

EQUITY ALERT UPDATE: Rosen Law Firm Expands Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. On Behalf Of Options Purchasers And Sellers

EQUITY ALERT UPDATE: Rosen Law Firm Expands Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. On Behalf Of Options Purchasers And Sellers

Rosen Law Firm, a global investor rights law firm, has filed a class action lawsuit on behalf of all purchasers of the common stock and call options and sellers of put options of Tetraphase Pharmaceuticals, Inc.

INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Reminds Investors With Losses To Contact The Firm

INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Reminds Investors With Losses To Contact The Firm

Lundin Law PC announces a class action lawsuit has been filed against Tetraphase Pharmaceuticals, Inc.

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Reminds Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Reminds Investors With Losses To Contact The Firm

Lundin Law PC announces a class action lawsuit has been filed against Tetraphase Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Lundin Law PC Announces Ongoing Investigation Of Tetraphase Pharmaceuticals, Inc. And Urges Investors To Contact The Firm

SHAREHOLDER ALERT: Lundin Law PC Announces Ongoing Investigation Of Tetraphase Pharmaceuticals, Inc. And Urges Investors To Contact The Firm

Lundin Law PC announces it is investigating claims against Tetraphase Pharmaceuticals, Inc.

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Tetraphase Pharmaceuticals Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of March 28, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Tetraphase Pharmaceuticals Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of March 28, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Tetraphase Pharmaceuticals Inc.

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Lawsuit Involving Tetraphase Pharmaceuticals Inc. And A Lead Plaintiff Deadline Of March 28, 2016

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Lawsuit Involving Tetraphase Pharmaceuticals Inc. And A Lead Plaintiff Deadline Of March 28, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Tetraphase Pharmaceuticals Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Tetraphase Pharmaceuticals Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of March 28, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Tetraphase Pharmaceuticals Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of March 28, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Tetraphase Pharmaceuticals Inc.

Tetraphase Pharmaceuticals Reports Fourth-Quarter And Full-Year 2015 Financial Results And Provides Corporate Update

Tetraphase Pharmaceuticals Reports Fourth-Quarter And Full-Year 2015 Financial Results And Provides Corporate Update

- Company to Host Conference Call at 4:30 p.m. ET Today -